tiprankstipranks
Trending News
More News >

Botanix Pharmaceuticals Announces Director Departure

Story Highlights
Botanix Pharmaceuticals Announces Director Departure

Confident Investing Starts Here:

Botanix Pharmaceuticals Limited ( (AU:BOT) ) just unveiled an announcement.

Botanix Pharmaceuticals Limited announced the cessation of Matthew Callahan as a director, effective May 23, 2025. The announcement details Callahan’s interests in the company, including a significant holding of fully paid ordinary shares and performance rights. This change in directorship may impact the company’s governance and strategic direction, influencing stakeholder confidence and market perception.

More about Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of dermatology and antimicrobial products. The company aims to address unmet needs in skin health through innovative therapies.

Average Trading Volume: 10,516,008

Technical Sentiment Signal: Hold

Current Market Cap: A$742.5M

Find detailed analytics on BOT stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App